ORIGINAL PAPER
Pain as a determinant of the emotional state of women after radical cancer surgery and chemotherapy
Submission date: 2014-10-24
Final revision date: 2014-12-01
Acceptance date: 2014-12-01
Publication date: 2015-01-11
Medical Studies 2014;30(4):241-246
KEYWORDS
TOPICS
ABSTRACT
Introduction: Cancer pain is chronic pain resulting from various mechanisms related to the natural history of the disease, the course of therapy, and psychosocial factors.
Aim of the research: To assess the relationship between the intensity of cancer pain in women at the final stage of chemotherapy following radical surgery of breast cancer, and the intensity of negative emotional reactions.
Material and methods: The study was conducted in a population of 118 women after radical surgical treatment of breast cancer and undergoing chemotherapy at the Chemotherapy Unit of the Holycross Cancer Centre in Kielce in 2011. The research methodology consisted of a diagnostic survey and medical documentation review.
Results: Strong emotional stress manifested by anxiety and depression was experienced by 48.3% and 29.7% of patients, respectively. Aggression was experienced by 15.2%. Intensification of pain was associated with the intensification of anxiety (r = 0.37; p < 0.0001), depression (r = 0.35; p < 0.01), and aggression (r = 0.30; p < 0.01).
Conclusions: Adherence to the WHO-recommended analgesic ladder regimen is an effective means to treat chronic cancer pain in women in the final stage of chemotherapy following radical surgical treatment. Effective pharmacotherapy of cancer pain significantly contributes to a reduction in the intensity of negative emotional reactions, i.e. anxiety, depression, and aggression in patients undergoing chemotherapy following mastectomy. Breast cancer chemotherapy is associated with high levels of anxiety, pain, and aggression being experienced by the patients. Pain is an important determinant of the emotional state of women undergoing chemotherapy following radical cancer surgery.
Aim of the research: To assess the relationship between the intensity of cancer pain in women at the final stage of chemotherapy following radical surgery of breast cancer, and the intensity of negative emotional reactions.
Material and methods: The study was conducted in a population of 118 women after radical surgical treatment of breast cancer and undergoing chemotherapy at the Chemotherapy Unit of the Holycross Cancer Centre in Kielce in 2011. The research methodology consisted of a diagnostic survey and medical documentation review.
Results: Strong emotional stress manifested by anxiety and depression was experienced by 48.3% and 29.7% of patients, respectively. Aggression was experienced by 15.2%. Intensification of pain was associated with the intensification of anxiety (r = 0.37; p < 0.0001), depression (r = 0.35; p < 0.01), and aggression (r = 0.30; p < 0.01).
Conclusions: Adherence to the WHO-recommended analgesic ladder regimen is an effective means to treat chronic cancer pain in women in the final stage of chemotherapy following radical surgical treatment. Effective pharmacotherapy of cancer pain significantly contributes to a reduction in the intensity of negative emotional reactions, i.e. anxiety, depression, and aggression in patients undergoing chemotherapy following mastectomy. Breast cancer chemotherapy is associated with high levels of anxiety, pain, and aggression being experienced by the patients. Pain is an important determinant of the emotional state of women undergoing chemotherapy following radical cancer surgery.
REFERENCES (26)
1.
Jarosz J, Hilgier M. Zasady diagnostyki i leczenia bólu. In: Podstawy opieki paliatywnej. de Walden-Gałuszko (ed.). PZWL, Warsaw 2007; 20-49.
2.
Kulpa M, Stypuła-Ciuba B. Ból nowotworowy i uciążliwość objawów somatycznych a jakość życia u pacjentów z chorobami nowotworowymi. Med Paliat 2013; 5: 171-9.
3.
Schou Bredal I, Smeby NA, Ottesen S, et al. Chronic pain in breast cancer survivors: comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain. J Pain Symptom Manage 2014; 48: 852-62.
4.
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 2007; 18: 1437-49.
5.
Dobrogowski J, Krajnik M, Jassem J, et al. Stanowisko dotyczące postępowania przeciwbólowego u chorych na nowotwory. Onkol Prakt Klin 2009; 2: 55-68.
6.
Ciałkowska-Rysz A, Dzierżanowski T. Podstawowe zasady farmakoterapii bólu u chorych na nowotwory i inne przewlekłe, postępujące, zagrażające życiu choroby. Med Paliat 2014; 6: 1-6.
7.
de Walden-Gałuszko K, Majkowicz M. Ocena jakości opieki paliatywnej w teorii i praktyce. Zakład Medycyny Paliatywnej, Akademia Medyczna w Gdańsku, Gdańsk 2000.
8.
Brzeziński K. Obwodowa neuropatia wywołana chemioterapią. Część II. Zapobieganie. Współcz Onkol 2012; 16: 262-5.
9.
Gärtner R, Jensen MB, Nielsen J, et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 2009; 302: 1985-92.
10.
Belfer I, Schreiber KL, Shaffer JR, et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain 2013; 14: 1185-5.
11.
Sheridan D, Foo I, O’Shea H, et al. Long-term follow-up of pain and emotional characteristics of women after surgery for breast cancer. J Pain Symptom Manage 2012; 44: 608-14.
12.
Bischoff K, Weinberg V, Rabow MW. Palliative and oncologic co-management: symptom management for outpatients with cancer. Support Care Cancer 2013; 21: 3031-7.
13.
Pacian A, Kulik TB, Skórzyńska H, et al. Rola wsparcia w bólu nowotworowym. Med Paliat 2014; 6: 95-10.
14.
Brzeziński K, Chwedorowicz R. Opioidy w leczeniu polineuropatii wywołanej chemioterapią. Współcz Onkol 2011; 15: 251-5.
15.
Pickering G, Morel V, Joly D, et al. Prevention of post-mastectomy neuropathic pain with memantine: study protocol for a randomized controlled trial. Trials 2014; 15: 331.
16.
Dzierżanowski T, Ciałkowska-Rysz A. Leki przeciwdrgawkowe w leczeniu adiuwantowym bólu nowotworowego. Med Paliat 2012; 4: 197-203.
17.
Grabińska K, Szewczyk-Cisek I, Hernik P, et al. Problemy i potrzeby psychosocjalne pacjentów poddanych chemioterapii onkologicznej. Psychoonkologia 2011; 2: 39-47.
18.
Helen JC, Lydersen S, Klepstad P. The Brief Pain Inventory: pain’s interference with functions is different in cancer pain compared with noncancer chronic pain. Clin J Pain 2008; 24: 219-25.
19.
Stepień R, Wrońska I. Lęk i depresja jako emocjonalne uwarunkowania możliwości funkcjonalnych kobiet po radykalnym leczeniu raka piersi. Stud Med 2008; 10: 31-5.
20.
Kulpa M, Owczarek K, Stypuła-Ciuba B. Przystosowanie psychiczne do choroby nowotworowej a jakość życia uwarunkowana stanem zdrowia u chorych onkologicznie. Med Paliat 2013; 4: 106-13.
21.
Kim MY. Transition of symptoms and quality of life in cancer patients on chemotherapy. J Korean Acad Nurs 2009; 39: 433-45.
22.
Groenvold M. Health-related quality of life in early breast cancer. Dan Med Bull 2010; 57: B4184.
23.
Lim CC, Devi MK, Ang E. Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J Evid Based Healthc 2011; 9: 215-35.
24.
de Walden-Gałuszko K, Majkowicz M, Zdun-Ryżewska A. Zaburzenia przystosowania do choroby nowotworowej – trudności diagnostyczne zespołów depresyjnych. Psychoonkologia 2013; 1: 10-5.
25.
Milik A. Przystosowanie się do choroby u kobiet z nowotworem piersi przed mastektomią i po niej oraz przed zabiegiem oszczędzającym i po tym zabiegu. Psychoonkologia 2013; 2: 50-5.
26.
Ogińska-Bulik N. Rola prężności psychicznej w przystosowaniu się kobiet do choroby nowotworowej. Psychoonkologia 2011; 1: 1-10.
| eISSN: | 2300-6722 |
| ISSN: | 1899-1874 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
